Deconstructing pancreatic cancer using next generation-omic technologies–from discovery to knowledge-guided platforms for better patient management

Schreyer, D., Neoptolemos, J. P., Barry, S. T. and Bailey, P. J. (2022) Deconstructing pancreatic cancer using next generation-omic technologies–from discovery to knowledge-guided platforms for better patient management. Frontiers in Cell and Developmental Biology, 9, 795735. (doi: 10.3389/fcell.2021.795735) (PMID:35096825) (PMCID:PMC8793685)

[img] Text
260106.pdf - Published Version
Available under License Creative Commons Attribution.

1MB

Abstract

Comprehensive molecular landscaping studies reveal a potentially brighter future for pancreatic ductal adenocarcinoma (PDAC) patients. Blood-borne biomarkers obtained from minimally invasive “liquid biopsies” are now being trialled for early disease detection and to track responses to therapy. Integrated genomic and transcriptomic studies using resectable tumour material have defined intrinsic patient subtypes and actionable genomic segments that promise a shift towards genome-guided patient management. Multimodal mapping of PDAC using spatially resolved single cell transcriptomics and imaging techniques has identified new potentially therapeutically actionable cellular targets and is providing new insights into PDAC tumour heterogeneity. Despite these rapid advances, defining biomarkers for patient selection remain limited. This review examines the current PDAC cancer biomarker ecosystem (identified in tumour and blood) and explores how advances in single cell sequencing and spatially resolved imaging modalities are being used to uncover new targets for therapeutic intervention and are transforming our understanding of this difficult to treat disease.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Schreyer, Mr Daniel and Bailey, Dr Peter
Authors: Schreyer, D., Neoptolemos, J. P., Barry, S. T., and Bailey, P. J.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Frontiers in Cell and Developmental Biology
Publisher:Frontiers Media
ISSN:2296-634X
ISSN (Online):2296-634X
Copyright Holders:Copyright © 2022 Schreyer, Neoptolemos, Barry and Bailey
First Published:First published in Frontiers in Cell and Developmental Biology 9: 795735
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
306698PancREatic Cancer OrganoiDs rEsearch NetworkPeter BaileyEuropean Commission (EC)861196CS -Translational Research Centre